Institutional Ownership Eye Point Pharmaceuticals, Inc. (EYPT)
This table provides information about the institutional ownership of Eye Point Pharmaceuticals, Inc. (EYPT). We have compiled data on the 167 institutions that hold shares in the stock, with a total of 71.7 Million shares, which have been reported (via 13F filing form) to have a value of $755 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Principia Wealth Advisory, LLC
Dallas, TX |
Apr 11, 2025 Q1 2025 |
533,778
shares
|
$5.63 Million
2.34% of portfolio
|
Q1 2025
Added 97.42%
|
|
Woodline Partners LP
San Francisco, CA |
May 15, 2025 Q1 2025 |
500,335
shares
|
$5.27 Million
0.02% of portfolio
|
Q1 2025
Reduced 0.28%
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
395,345
shares
|
$4.17 Million
0.0% of portfolio
|
Q1 2025
Reduced 0.03%
|
|
Ubs Group Ag
|
May 13, 2025 Q1 2025 |
387,079
shares
|
$4.08 Million
0.0% of portfolio
|
Q1 2025
Reduced 32.09%
|
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
May 09, 2025 Q1 2025 |
357,442
shares
|
$3.77 Million
0.0% of portfolio
|
Q4 2024
Reduced 40.3%
|
|
Alyeska Investment Group, L.P.
Chicago, IL |
May 15, 2025 Q1 2025 |
351,348
shares
|
$3.7 Million
0.01% of portfolio
|
Q4 2024
Added 39.79%
|
|
Two Sigma Investments, LP
New York, NY |
May 15, 2025 Q1 2025 |
323,860
shares
|
$3.41 Million
0.0% of portfolio
|
Q1 2025
Reduced 8.5%
|
|
Artia Global Partners LP
Miami, FL |
May 15, 2025 Q1 2025 |
316,700
shares
|
$3.34 Million
0.43% of portfolio
|
Q1 2025
Added 46.15%
|
|
Wells Fargo & Company
San Francisco, CA |
May 13, 2025 Q1 2025 |
271,611
shares
|
$2.86 Million
0.0% of portfolio
|
Q1 2025
Added 680.67%
|
|
Axa S.A.
Paris, I0 |
May 15, 2025 Q1 2025 |
262,809
shares
|
$2.77 Million
0.0% of portfolio
|
Q1 2025
Reduced 0.13%
|
|
Schroder Investment Management Group
London, X0 |
May 13, 2025 Q1 2025 |
257,985
shares
|
$2.72 Million
0.0% of portfolio
|
Q1 2025
Reduced 4.57%
|
|
Wellington Management Group LLP
Boston, MA |
May 13, 2025 Q1 2025 |
233,231
shares
|
$2.46 Million
0.0% of portfolio
|
Q1 2025
New holding
|
|
Abrdn PLC
|
May 13, 2025 Q1 2025 |
230,745
shares
|
$2.43 Million
0.0% of portfolio
|
Q4 2024
New holding
|
|
Laurion Capital Management LP
New York, NY |
May 15, 2025 Q1 2025 |
210,006
shares
|
$2.21 Million
0.03% of portfolio
|
Q1 2025
Added 2.15%
|
|
Susquehanna Fundamental Investments, LLC
Bala Cynwyd, PA |
May 14, 2025 Q1 2025 |
206,605
shares
|
$2.18 Million
0.02% of portfolio
|
Q1 2025
Added 66.93%
|
|
Nuveen, LLC
Charlotte, NC |
May 12, 2025 Q1 2025 |
194,897
shares
|
$2.05 Million
0.0% of portfolio
|
Q1 2025
New holding
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
May 09, 2025 Q1 2025 |
191,144
shares
|
$2.01 Million
0.0% of portfolio
|
Q1 2025
Reduced 0.01%
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
183,949
shares
|
$1.94 Million
0.0% of portfolio
|
Q4 2024
Added 7.63%
|
|
Myda Advisors LLC
Inwood, NY |
May 14, 2025 Q1 2025 |
180,000
shares
|
$1.9 Million
0.18% of portfolio
|
Q1 2025
Added 12.5%
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
May 14, 2025 Q1 2025 |
148,049
shares
|
$1.56 Million
0.0% of portfolio
|
Q1 2025
Added 55.6%
|
|
Essex Investment Management CO LLC
Boston, MA |
May 07, 2025 Q1 2025 |
124,583
shares
|
$1.31 Million
0.15% of portfolio
|
Q1 2025
Reduced 0.66%
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
May 14, 2025 Q1 2025 |
117,300
shares
|
$1.24 Million
0.0% of portfolio
|
Q1 2025
Reduced 14.69%
|
|
Panagora Asset Management Inc
Boston, MA |
May 15, 2025 Q1 2025 |
116,099
shares
|
$1.22 Million
0.0% of portfolio
|
Q1 2025
Added 5.02%
|
|
Swiss National Bank
Zurich, V8 |
May 12, 2025 Q1 2025 |
112,400
shares
|
$1.18 Million
0.0% of portfolio
|
Q1 2025
Added 12.4%
|
|
Gsa Capital Partners LLP
London, X0 |
Jul 22, 2025 Q2 2025 |
99,764
shares
|
$1.05 Million
0.07% of portfolio
|
Q2 2025
New holding
|